| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.19 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |